16th February 2021 – Biotherapy Services Ltd re-open trial to recruitment at Loughborough Hospital.  

 Amidst difficult times, BTS are pleased to announce the RAPID-1 DFU clinical trial is open to recruitment at the Loughborough site. Working throughout the past year BTS has established a working partnership at Loughborough Hospital to create a safe environment to expand the trial and provide treatments for patients. The staff are looking forward to assessing and welcoming new patients for the trial from the Leicestershire and Rutland areas. 

 The RAPID-1 DFU trial is seeking to offer help to diabetic patients suffering with chronic foot ulcers that have not healed for 12 weeks or more, using a novel treatment harnessing the power of their own blood.  

 “This is a watershed moment for the company adapting the trial to build in additional requirements to keep patients safe due to Covid 19, gaining regulatory approvals to become one of the  first non-Covid commercial trail to open in the UK since the start of the Pandemic.” 

James Rickard, Chief Scientific and Regulatory Officer at BTS. 

For more information contact info@lisat86.sg-host.com 

RAPID™  [Restorative Autologous Platelet biotherapies for Injuries and Delayed wound healing]. [/vc_column_text][/vc_column][/vc_row]